Viewing Study NCT04029857

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:44 PM

Ignite Modification Date: 2026-02-20 @ 4:47 PM

Study NCT ID: NCT04029857

Status: WITHDRAWN

Last Update Posted: 2024-02-13

First Post: 2019-07-19

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery

Sponsor: M.D. Anderson Cancer Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief	Condition Text	View

None	Clinical Stage III Esophageal Adenocarcinoma AJCC v8	View
None	Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8	View
None	Pathologic Stage III Esophageal Adenocarcinoma AJCC v8	View
None	Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8	View
None	Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8	View
None	Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8	View
None	Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8	View
None	Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8	View
None	Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8	View
None	Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8	View
None	Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8	View
None	Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8	View
None	Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8	View
None	Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8	View
None	Resectable Mass	View

Keywords: